Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study (RESPECT)
Sponsor: East and North Hertfordshire NHS Trust
Listed as NCT03266744, this NA trial focuses on Metastatic Breast Cancer and remains ongoing. Sponsored by East and North Hertfordshire NHS Trust, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Sep 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
▶ Show 1 earlier version
-
Sep 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- East and North Hertfordshire NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.